Abingdon Health (LON:ABDX) Announces Quarterly Earnings Results

Abingdon Health (LON:ABDX) released its quarterly earnings data on Tuesday. The company reported GBX (0.51) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Stock Performance

Shares of LON:ABDX traded down GBX 0.85 on Wednesday, hitting GBX 8.65. 350,495 shares of the company were exchanged, compared to its average volume of 236,617. The stock’s 50 day moving average price is GBX 10.74 and its 200 day moving average price is GBX 10.52. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The firm has a market capitalization of £21.86 million, a P/E ratio of -10.68 and a beta of 0.13. Abingdon Health has a 1-year low of GBX 5.50 and a 1-year high of GBX 13.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.